Fingerprint
Dive into the research topics of 'Bempegaldesleukin plus nivolumab in untreated, unresectable or metastatic melanoma: Phase III PIVOT IO 001 study design'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Bempegaldesleukin plus nivolumab in untreated, unresectable or metastatic melanoma: Phase III PIVOT IO 001 study design
Nikhil I. Khushalani, Adi Diab, Paolo A. Ascierto, James Larkin, Shahneen Sandhu, Mario Sznol, Henry B. Koon, Anthony Jarkowski, Ming Zhou, Paul Statkevich, William J. Geese, Georgina V. Long
Research output: Contribution to journal › Article › peer-review
19
Scopus
citations